4//SEC Filing
Olinger Margaret 4
Accession 0000950170-23-073837
CIK 0001658551other
Filed
Dec 28, 7:00 PM ET
Accepted
Dec 29, 4:07 PM ET
Size
6.6 KB
Accession
0000950170-23-073837
Insider Transaction Report
Form 4
Olinger Margaret
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2023-12-27$0.37/sh+25,000$9,250→ 276,108 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-12-27−25,000→ 44,577 totalExercise: $0.37Exp: 2029-05-13→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option are fully vested and exercisable.
Documents
Issuer
Amylyx Pharmaceuticals, Inc.
CIK 0001658551
Entity typeother
Related Parties
1- filerCIK 0001898725
Filing Metadata
- Form type
- 4
- Filed
- Dec 28, 7:00 PM ET
- Accepted
- Dec 29, 4:07 PM ET
- Size
- 6.6 KB